Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.

Krejci, M; Brychtova, Y; Doubek, M; Tomiska, M; Navratil, M; Racil, Z; Dvorakova, D; Horky, O; Lengerova, M; Pospisilova, S; Mayer, J

Krejci, M; Brychtova, Y; Doubek, M; Tomiska, M; Navratil, M; Racil, Z; Dvorakova, D; Horky, O; Lengerova, M; Pospisilova, S; Mayer, J.

Affiliation

Krejci M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Jihlavska, Czech Republic. mkrejci@fnbrno.cz

Neoplasma ; 58(5): 406-14, 2011.

Article in En | MEDLINE | ID: mdl-21744994

Subject(s)

Antilymphocyte Serum/therapeutic use; Busulfan/therapeutic use; Hematologic Neoplasms/therapy; Hematopoietic Stem Cell Transplantation; Transplantation Conditioning; Vidarabine/analogs & derivatives; Adolescent; Adult; Aged; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease/prevention & control; Hematologic Neoplasms/mortality; Humans; Immunosuppressive Agents/therapeutic use; Male; Middle Aged; Survival Rate; Time Factors; Transplantation, Homologous; Treatment Outcome; Vidarabine/therapeutic use; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Vidarabine / Busulfan / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Transplantation Conditioning / Antilymphocyte Serum Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neoplasma Year: 2011 Type: Article Affiliation country: Czech Republic

Search on Google

Add to My VHL

XML

PubMed Links